Daniel Skovronsky is Director of MYRIAD GENETICS INC. Currently has a direct ownership of 86,010 shares of MYGN, which is worth approximately $1.25 Million. The most recent transaction as insider was on Jun 06, 2024, when has been sold 15,695 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 86K
0% 3M change
22.32% 12M change
Total Value Held $1.25 Million

Daniel Skovronsky Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 06 2024
BUY
Grant, award, or other acquisition
-
15,695 Added 15.43%
86,010 Common Stock
Jun 01 2023
BUY
Grant, award, or other acquisition
-
15,151 Added 17.73%
70,315 Common Stock
Jun 02 2022
BUY
Grant, award, or other acquisition
-
17,275 Added 23.85%
55,164 Common Stock
Jun 03 2021
BUY
Grant, award, or other acquisition
-
12,848 Added 25.32%
37,889 Common Stock
Dec 04 2020
BUY
Grant, award, or other acquisition
-
15,889 Added 27.96%
40,930 Common Stock

Also insider at

LLY
ELI LILLY & Co Healthcare
DS

Daniel Skovronsky

Director
Indianapolis, IN

Track Institutional and Insider Activities on MYGN

Follow MYRIAD GENETICS INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells MYGN shares.

Notify only if

Insider Trading

Get notified when an Myriad Genetics Inc insider buys or sells MYGN shares.

Notify only if

News

Receive news related to MYRIAD GENETICS INC

Track Activities on MYGN